Department of Microbiology, 7164San Juan Bautista School of Medicine, Puerto Rico.
Chronic Illn. 2022 Dec;18(4):889-900. doi: 10.1177/17423953211043104. Epub 2021 Sep 20.
To estimate the epidemiology of sarcoidosis in Puerto Rico.
Patients with a diagnosis of sarcoidosis between January 2015 and December 2018 were selected from the Puerto Rico Health Insurance Administration Administración de Seguros de Salud de Puerto Rico claims database. The International Classification of Diseases-Tenth Revision coding for sarcoidosis was used for case detection and utilization of health care services. Cases by sex and age were evaluated.
A total of 488 individuals with sarcoidosis were identified over the 4-year study. The median age at diagnosis was 59 years old. The average annual incidence rate was 9.9/100,000. The baseline prevalence was 14.9 per 100,000. Females represented 68.4% of the cases. Patients with lung and unspecified sarcoidosis predominate with 45.6% and 28.2% of cases, respectively. Overall, the yearly cost of health care utilization and medications per patient was $234 and $13,638, respectively.
Annual incidence rate and the median age of sarcoidosis in Puerto Ricans are among the highest and oldest reported globally. The demographic profile of sarcoidosis in Puerto Rico presents a patient in the mid-to advanced age, mostly female. While costs for medications were relatively high for a patient with sarcoidosis, the economic burden of the disease to the national health care system is not substantial.
估计波多黎各的结节病流行病学。
从波多黎各健康保险管理局（Administración de Seguros de Salud de Puerto Rico）理赔数据库中选取了 2015 年 1 月至 2018 年 12 月期间被诊断为结节病的患者。使用国际疾病分类第十次修订版（International Classification of Diseases-Tenth Revision）的结节病编码进行病例检测和利用医疗服务。按性别和年龄评估病例。
在 4 年的研究中，共发现 488 例结节病患者。诊断时的中位年龄为 59 岁。平均年发病率为 9.9/100,000。基线患病率为 14.9/100,000。女性占病例的 68.4%。肺部和未特指的结节病患者分别占 45.6%和 28.2%。总体而言，每位患者每年的医疗保健利用费用和药物费用分别为 234 美元和 13,638 美元。
波多黎各结节病的年发病率和中位年龄均为全球最高和最年长的。波多黎各结节病的人口统计学特征为年龄在中年至老年的女性患者居多。虽然结节病患者的药物费用相对较高，但该病对国家医疗保健系统的经济负担并不严重。
